A 173-patient randomized trial in HFrEF (LVEF ≤35%) with LBBB (QRS ≥130 ms) showed CSP was inferior to BiVP for a hierarchical 12‑month composite endpoint. Worse outcomes with CSP were reflected by an ...
The OmniaSecure lead gained the first U.S. approval for placement in the heart’s left bundle branch area, to help activate ...
Medtronic snagged FDA approval for an expanded indication for its OmniaSecure defibrillation lead. Check out why this tiny ...
Medtronic (NYSE: MDT) announced today that it received FDA approval for an expanded indication for its OmniaSecure defibrillation lead.
The findings suggest that use of the pacing technique during CRT should be reserved for expert operators, at least for now.
Medtronic and Biotronik both took steps forward this week with their pacemaker hardware designed to target newly emerging ...
Want music on your outdoor runs without losing street awareness? See how open‑ear and bone‑conduction headphones stack up.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results